NK细胞在急性冠脉综合征中的作用及机制研究进展

摘要/Abstract

摘要： 急性冠脉综合征（acute coronary syndrome,ACS）可导致心力衰竭、心律失常甚至猝死,是世界范围内残疾和死亡的主要原因之一。NK细胞作为机体固有免疫的重要组成部分,与ACS的发生、发展及心肌梗死后的损伤修复密切相关。本文针对NK细胞在ACS中的作用及机制进行综述,以期为ACS发病机制阐明及治疗提供新思路。

关键词: NK细胞, 急性冠脉综合征, 急性心肌梗死, 动脉粥样硬化, 炎症

王家琦, 吴路路, 王禹丹, 张飞飞, 党懿, 齐晓勇. NK细胞在急性冠脉综合征中的作用及机制研究进展[J]. 心血管病防治知识, 2022, 12(6): 91-94.

[1] 中国心血管健康与疾病报告2020概要[J].中国循环杂志,2021,36(6):521-545.
[2] Zhu Y, Xian X, Wang Z, et al.Research Progress on the Relationship between Atherosclerosis and Inflammation[J]. Biomolecules,2018,8(3):80.
[3] Winkels H,Ehinger E,Ghosheh Y,et al.Atherosclerosis in the single-cell era.[J].Curr Opin Lipidol,2018,5:389-396.
[4] Selathurai A,Deswaerte V,Kanellakis P,et al.Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms.[J].Cardiovasc Res,2014,1:128-137.
[5] Souilhol C,Harmsen MC,Evans PC,et al.Endothelial-mesenchymal transition in atherosclerosis.[J].Cardiovasc Res,2018,4:565-577.
[6] Simionescu M.Implications of early structural-functional changes in the endothelium for vascular disease.[J].Arterioscler Thromb Vasc Biol,2007,2:266-274.
[7] Crea F,Libby P.Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.[J].Circulation,2017,12:1155-1166.
[8] Zhou J,Li YS,Chien S.Shear stress-initiated signaling and its regulation of endothelial function.[J].Arterioscler Thromb Vasc Biol,2014,10:2191-2198.
[9] Lluberas N, Trías N, Brugnini A, et al.Lymphocyte subpopulations in myocardial infarction: a comparison between peripheral and intracoronary blood[J].Springerplus. 2015,4:744.
[10] Theodorou K,Boon RA.Endothelial Cell Metabolism in Atherosclerosis[J].Front Cell Dev Biol,2022,:82.
[11] Nahrendorf M,Swirski FK,Aikawa E,et al.The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.[J].J Exp Med,2007,12:3037-3047.
[12] Mentz RJ,Bakris GL,Waeber B,et al.The past, present and future of renin-angiotensin aldosterone system inhibition.[J].Int J Cardiol,2013,5:1677-1687.
[13] Kumric M,Kurir TT,Borovac JA,et al.The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review[J].Biomolecules,1970,11.
[14] Ong SB,Hernández-Reséndiz S,Crespo-Avilan GE,et al.Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.[J].Pharmacol Ther,2018:73-87.
[15] Wang X,Guo Z,Ding Z,et al.Inflammation, Autophagy, and Apoptosis After Myocardial Infarction.[J].J Am Heart Assoc,2018,9.
[16] Winkels H,Ley K.Natural Killer Cells at Ease: Atherosclerosis Is Not Affected by Genetic Depletion or Hyperactivation of Natural Killer Cells.[J].Circ Res,2018,1:6-7.
[17] Engelbertsen D,Autio A,Verwilligen RAF,et al.Increased lymphocyte activation and atherosclerosis in CD47-deficient mice.[J].Sci Rep,2019,1:10608.
[18] Knorr M,Münzel T,Wenzel P.Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction.[J].Front Physiol,2014:295.
[19] Bonaccorsi I,Spinelli D,Cantoni C,et al.Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands.[J].Front Immunol,2022:1503.
[20] Nour-Eldine W,Joffre J,Zibara K,et al.Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development.[J].Circ Res,2018,1:47-57.
[21] Jonasson L,Backteman K,Ernerudh J.Loss of natural killer cell activity in patients with coronary artery disease.[J].Atherosclerosis,2005,2:316-21.
[22] Laskarin G,Persic V,Ruzic A,et al.Perforin-mediated cytotoxicity in non-ST elevation myocardial infarction.[J].Scand J Immunol,2011,2:195-204.
[23] Backteman K,Ernerudh J,Jonasson L.Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation.[J].Clin Exp Immunol,2014,1:104-112.
[24] Hong YJ,Cho YN,Kim TJ,et al.Functional deficiency of natural killer cells in acute coronary syndrome is related to ineffective degranulation.[J].Int J Cardiol,2014,3:613-615.
[25] Kumric M,Kurir TT,Borovac JA,et al.The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review.[J].Biomolecules,1970,11.
[26] Aranha FC, Ribeiro U Jr, Basse P, et al.Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection[J]. Scandinavian journal of immunology, 2005, 62(4): 334-341.
[27] Ayach BB,Yoshimitsu M,Dawood F,et al.Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.[J].Proc Natl Acad Sci U S A,2006,7:2304-2309.
[28] Bouchentouf M,Williams P,Forner KA,et al.Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction.[J].Cytokine,2011,3:732-738.
[29] Yan W,Song Y,Zhou L,et al.Immune Cell Repertoire and Their Mediators in Patients with Acute Myocardial Infarction or Stable Angina Pectoris.[J].Int J Med Sci,2017,2:181-190.
[30] Matsumoto K,Obana M,Kobayashi A,et al.Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.[J].Cardiovasc Res,2019,4:765-775.
[31] Wang J,Chen Z,Dai Q,et al.Intravenously delivered mesenchymal stem cells prevent microvascular obstruction formation after myocardial ischemia/reperfusion injury[J].Basic Res Cardiol,2020,4:40.

NK细胞在急性冠脉综合征中的作用及机制研究进展

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	叶陈柳, 郭欢欢, 郑金花, 罗树宏. 冠心舒通胶囊对急性心肌梗死患者疗效及对炎症反应、再狭窄的影响[J]. 心血管病防治知识, 2023, 13(9): 13-15.
[2]	杨杰锋, 王建茹. 急性心肌梗死患者院前急救护理的价值[J]. 心血管病防治知识, 2023, 13(9): 87-89.
[3]	谢冰华, 赖婷婷, 傅萍燕. hs-cTnI、HMGB1、sTLT-1在急性冠脉综合征患者PCI术后MACE预测中的应用价值[J]. 心血管病防治知识, 2023, 13(8): 3-5.
[4]	沈凤珍, 沈振梁, 谢芳婧. 血清Hcy、LPPLA2、PTX3水平与H型高血压颈动脉粥样硬化程度的关系[J]. 心血管病防治知识, 2023, 13(8): 9-11.
[5]	邓微微, 叶水芬, 钟锦荣. 老年H型高血压患者Hcy水平与其心肾靶器官损害的相关性研究[J]. 心血管病防治知识, 2023, 13(8): 22-25.
[6]	黄光秀, 廖美艳, 池青, 廖思钦, 邹文毕. 荧光免疫微流定量检测急性心肌梗死三联的临床诊断价值[J]. 心血管病防治知识, 2023, 13(7): 19-21.
[7]	杨可娜, 岳媛萍, 张俊玲, 沈爱苹, 付春丽. 急性冠脉综合征患者居家安全风险现状和影响因素分析[J]. 心血管病防治知识, 2023, 13(7): 34-37.
[8]	文武. 多样化护理干预在ICU急性心肌梗死合并糖尿病危重患者中的应用[J]. 心血管病防治知识, 2023, 13(7): 47-49.
[9]	陈丽, 林苹青, 林玲燕. 基于分级分区管理的结局导向多维度零缺陷急诊救护对急性心肌梗死患者预后的影响观察[J]. 心血管病防治知识, 2023, 13(6): 43-45.
[10]	周茜. 重组人脑利钠肽联合参附注射液治疗急性心肌梗死合并心力衰竭的效果分析[J]. 心血管病防治知识, 2023, 13(5): 3-5.
[11]	蒋科善. 基于LACE风险模型下的延续性护理对急性心肌梗死PCI术后患者的应用效果[J]. 心血管病防治知识, 2023, 13(5): 80-83.
[12]	柳萍萍. 系统护理对老年高血压动脉粥样硬化患者血压和生活方式的影响[J]. 心血管病防治知识, 2023, 13(5): 94-96.
[13]	刘郎. 参松养心胶囊联合沙库巴曲缬沙坦对急性心肌梗死合并心律失常患者心室重塑、炎症因子的影响[J]. 心血管病防治知识, 2023, 13(4): 3-5.
[14]	鞠晓安. 瑞替普酶治疗急性心肌梗死的作用及干预措施与血管再通率分析[J]. 心血管病防治知识, 2023, 13(4): 12-14.
[15]	郭丽云. 急性心肌梗死尿激酶溶栓患者不同时机应用低分子肝素的效果分析[J]. 心血管病防治知识, 2023, 13(3): 6-8.